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ABSTRACT
Cord blood transplantation has been used extensively in the allogeneic setting for acquired and genetic
disorders of hematopoiesis. There is less experience in the utility of autologous cord blood transplantation, and
there is great controversy about the role of autologous cord blood collection and storage. We report on the
successful use of autologous cord blood transplantation for the treatment of severe aplastic anemia following
fulminant hepatic failure and living related liver transplantation.
© 2004 American Society for Blood and Marrow Transplantation
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aWe report the ﬁrst case of autologous cord blood
ransplantation for the treatment of severe aplastic
nemia secondary to liver transplantation. A 20-
onth-old boy presented with fulminant hepatic fail-
re of unknown etiology. Markers for viral hepatitis
nd congenital causes of fulminant hepatic failure
ere negative. A living related liver transplantation
rom his haploidentical father was performed. Three
onths later, the patient developed pancytopenia
white blood cells 200/L; platelets 7000/L).
one marrow was empty on biopsy. Etiology for se-
ere aplastic anemia could not be determined. He
eceived increasing doses of cyclosporine and steroids
or immunomodulation. He remained neutropenic,
as dependent on transfusions of red blood cells and
latelets, and had no HLA-matched siblings. The pa-
ient’s parents, both physicians, had arranged for the
torage of the patient’s cord blood at birth. It was
ecided to use the stored cord blood as an autologous
ord blood transplant in an attempt to restore normal
ematopoiesis. A Nunc vial stored with the cord blood
as thawed to conﬁrm that it was HLA identical to the
atient. The preparative regimen consisted of antithy-
ocyte globulin 40 mg/kg/d, cyclosporine, and pred-
isone given for 4 days along with granulocyte colony-
timulating factor, followed by infusion of 7.98  107 b
B&MTotal nucleated cells per kilogram containing 2.79 
05 CD34 cells per kilogram. White blood cell en-
raftment (1000/L) occurred by day 11 and plate-
et engraftment by day 14 (20 000/L). The pa-
ient’s recovery was unremarkable, except for a skin
iopsy positive for Aspergillus spp, which was treated
ith antifungal agents. At 3 years of follow-up, the
atient remains on immunosuppressive therapy for his
mmunosuppressive regimen after living related liver
ransplantation and is in complete hematologic remis-
ion with a normal complete blood count.
Severe aplastic anemia, a life-threatening he-
atologic emergency requiring prompt treatment, has
een reported in certain settings to occur in up to
8% of recipients of orthotopic liver transplants [1].
arrow transplantation from an HLA-matched sib-
ing donor has high rates of cure in children with
plastic anemia [2], but matched or compatible donors
re not always available. In the absence of a matched
onor, immunosuppressive therapy can restore hema-
ologic function in some patients, but pancytopenia
requently recurs, and eventual transformation to my-
lodysplastic syndrome and acute leukemia is a risk.
Cord blood has been used for more than a decade
s a source of stem cells for allogeneic transplantation,
ut reports of its use in children with aplastic anemia
741
s
n
t
m
p
a
w
c
w
t
I
f
s
1
l
l
t
t
m
a
a
m
t
u
c
o
a
a
m
R
1
2
3
4
5
6
7
8
T
1
1
8
6
2
* recover
S. M. Fruchtman et al.
7econdary to liver transplantation are rare. In the
on–liver transplant setting, 2 cases of hematopoietic
ransplantation with allogeneic cord blood and bone
arrow from HLA-matched siblings have been re-
orted: one in a 7-year-old boy with acquired severe
plastic anemia [3] and the other in a 9-year-old girl
ith myelodysplastic syndrome due to hepatitis-asso-
iated aplastic anemia [4]. In both cases, engraftment
as prompt (1 month) and successful.
Three cases of severe aplastic anemia after ortho-
opic liver transplantation have been reported (Table 1).
n all cases, prompt hematopoietic recovery was success-
ully achieved by using marrow from HLA-matched
iblings [5-7]. Umeda et al. [8] described a case of a
-year-old boy who developed aplastic anemia after a
iving related liver transplantation from his HLA-hap-
oidentical father (Table 1). The patient was platelet
ransfusion dependent and developed 2 episodes of life-
hreatening intracranial hemorrhage while receiving im-
unosuppressive therapy. Marrow engraftment was
chieved by using stem cell transplantation with related
llogeneic cord blood and bone marrow from an HLA-
atched sibling.
To our knowledge, our case is the ﬁrst report of
he successful treatment of severe aplastic anemia by
sing only autologous cord blood. Of note, because T
ells derived from the cord will develop in the setting
f exposure to the HLA-disparate liver graft, there is
lso the possibility of inducing HLA-disparate toler-
nce; thus, the recipient may not require chronic im-
able 1. Cases of Hematopoietic Transplantation in Children with Seve
Patient Liver Transplant Type
Hem
Source
.6-year-old boy Living–related, HLA
haploidentical father
Cord bloo
-year-old boy [8] Living–related, HLA
haploidentical father
Cord bloo
-year-old boy [5] Orthotopic Marrow
.5-year-old boy [6] Orthotopic Marrow
.5-year-old boy [7] Orthotopic Marrow
Indicates recovery deﬁned as platelets  20,000/mm3. In other cases,unosuppression.
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